Biotechnology drug-discovery company developing AI-guided, multi-targeted immunotherapies from natural products produced by commensal microbes
Biotechnology drug-discovery company developing AI-guided, multi-targeted immunotherapies from natural products produced by commensal microbes. Its platform combines precision culturomics, targeted metabolomics, molecular engineering, and AI to identify and optimize low-toxicity, immune-modulating microbial metabolites for inflammatory diseases and other complex conditions, including autoimmune disorders and cancer.